SCHEMBL6806147

SCHEMBL6806147

COc1cc(S(C)(=O)=O)nc(O)n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
KCNH2 Q12809 1/20 0.35
GAA P10253 1/20 0.35
POLB P06746 1/20 0.33
TP53 P04637 1/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.33
TSHR P16473 1/20 0.32
RECQL P46063 1/20 0.32
PTGS2 P35354 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
CYP3A4 P08684 1/20 0.31
HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28026807 0.79 LMNA (0.55) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL5360302 0.79 LMNA (0.78) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL401293 0.77 CYP1A2 (0.48) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL6912864 0.76 LMNA (0.32) LMNASMN1; SMN2
SCHEMBL3691082 0.76 LMNA (0.55) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL8658127 0.76 SMN1; SMN2 (0.55) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL28506559 0.75 CYP1A2 (0.47) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL3439357 0.74 KDM4E (0.51) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL568577 0.73 KDM4E (0.69) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2
SCHEMBL1346260 0.73 LMNA (0.47) LMNASMN1; SMN2ALDH1A1KDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6693194-B2 BY REACTING 4,6-DICHLORO-2-(METHYLTHIO)PYRIMIDINE IN AN INERT ORGANIC SOLVENT WITH AN ALKALI METAL METHOXIDE, TRANSFERRING TO AN AQUEOUS ACID MEDIUM AND OXIDATION; USING THE PRODUCT TO PREPARE 7-((4,6- SYNGENTA CROP PROTECTION, INC. 2004-02-17 US disclosed
US-20030135047-A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine SYNGENTA CORP PROTECTION, INC. 2003-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030135047-A1 Process for the preparation of 4,6-dimethoxy-2-(methylsulfonyl)-1,3-pyrimidine TPMT, DHODH, DPYD LMNA 4325/4885SMN1; SMN2 897/4885ALDH1A1 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.